The directors are proposing an equity raise of $170M which would...

The directors are proposing an equity raise of $170M which would result in current shareholders retaining 4% exposure, if shareholders did not contribute towards the equity raise.

The directors have been given until next Friday to improve the terms of the recapitalisation proposal. If they succeed, the meeting will be adjourned.

If the DOCA passes, shareholders/directors can still challenge the 444GA order and if done successfully, will still retain exposure to Nullagine - Mark Creasy will only receive shares in Keras Pilbara and Calidus Blue.

I've had an email from Dave to say he is working to get some return for shareholders.